Experimental Melanoma Vaccine Shows Early Promise

April 2, 2015 6:00 PM

17 0

THURSDAY, April 2, 2015 (HealthDay News) -- A highly personalized vaccine can spur an immune response in people with advanced melanoma, a preliminary study finds.

The experimental vaccine was tested in just three patients, and experts stressed that the findings show only that it can coax an immune response -- not that it can effectively treat the potentially deadly skin cancer.

Read more

To category page